Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

6.2%

45 terminated/withdrawn out of 725 trials

Success Rate

89.0%

+2.5% vs industry average

Late-Stage Pipeline

20%

143 trials in Phase 3/4

Results Transparency

10%

38 of 364 completed trials have results

Key Signals

70 recruiting38 with results34 terminated11 withdrawn

Enrollment Performance

Analytics

N/A

175(32.2%)

Phase 2

169(31.1%)

Phase 4

85(15.6%)

Phase 3

58(10.7%)

Phase 1

56(10.3%)

Early Phase 1

1(0.2%)

544Total

N/A(175)

Phase 2(169)

Phase 4(85)

Phase 3(58)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (725)

Showing 20 of 725 trials

NCT07530393Not Yet Recruiting

Blood Viscosity and Outcomes After Elective Craniotomy

Role: lead

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT07089589Completed

Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients

Role: lead

NCT05805280Not ApplicableCompleted

IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease

Role: lead

NCT05801432Recruiting

A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus

Role: lead

NCT05418556Phase 4Recruiting

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Role: lead

NCT06757764Phase 4Recruiting

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

Role: lead

NCT07495579Phase 2Not Yet Recruiting

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

Role: lead

NCT07485855Phase 3Recruiting

Influenza Vaccination Strategy for Patients With Hematologic Malignancy

Role: lead

NCT07491029Not ApplicableNot Yet Recruiting

AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke

Role: collaborator

NCT07489092Not ApplicableRecruiting

Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge

Role: lead

NCT07010497Phase 2Recruiting

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

Role: lead

NCT07476235Completed

Predictors of Treatment Response to Stellate Ganglion Block in Cervical Radicular Pain

Role: lead

NCT06537193Not ApplicableRecruiting

Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

Role: lead

NCT07447297Not ApplicableRecruiting

Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

Role: collaborator

NCT07437573Phase 3Completed

Oncometabolic Surgery

Role: collaborator

NCT07431762Phase 4Not Yet Recruiting

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement

Role: lead

NCT07295769Not ApplicableRecruiting

Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause

Role: lead

NCT06086665Completed

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Role: lead

NCT07382505Not Yet Recruiting

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Role: lead